14 completed. 14 Phase 2, 4 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 14 | Completed 14 |
| Phase 3 | 4 | Completed 4 |
| Phase 1 | 1 | Completed 1 |
Follow Transdermal Patch: new trials by email Literature Review of Transdermal Patch trials Research Report on Transdermal Patch
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Remote vs. In-Person Study Evaluation (RISE) Trials: RISE Above Smoking (Trial 1 of 3) Combination Nicotine Replacement Therapy (patch and lozenge) - Remote vs. In-Person, Remote Visits | Phase 2 / Phase 3 | Completed | State University of New York at Buffalo | 200 | 2025-03-10 | 2026-11-05 |
| Transgender Estradiol Affirming Therapy Transdermal patch, Pro-thrombotic markers, Metabolic markers - Transgenderism | Phase 2 | Completed | Washington University School of Medicine | 39 | 2021-08-02 | 2024-11-26 |
| Study to Evaluate Pharmacokinetics Profile, Wearability, and Safety of 2 Progestin-Only Patches levonorgestrel - Healthy | Phase 1 / Phase 2 | Completed | Agile Therapeutics | 36 | 2012-07-01 | 2018-01-23 |
| Oleogel-S10 in Wound Healing of Inherited Epidermolysis Bullosa (BEB-10) Oleogel-S10, Mepilex® soft silicone faced polyurethane foam dressing - Inherited Epidermolysis Bullosa | Phase 2 | Completed | Birken AG | 10 | 2010-11-01 | 2018-01-23 |
| Use of Topical Lidocaine to Reduce Pain in Patients With Diabetic Neuropathy Skin biopsy, Lidocaine 5% patches - Diabetic Peripheral Neuropathy | Phase 2 / Phase 3 | Completed | Albany Medical College | 51 | 2009-10-01 | 2020-06-11 |
| Open-Label Study Evaluating Synera® in the Treatment of Patients With Carpal Tunnel Syndrome Synera (lidocaine 70 mg and tetracaine 70 mg) topical patch - Carpal Tunnel Syndrome | Phase 2 | Completed | ZARS Pharma Inc. | 24 | 2009-09-01 | 2012-03-16 |
| Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic Conjunctivitis Ketotifen 4.0% Patch, Placebo, Olopatadine 0.2% - Allergic Conjunctivitis | Phase 2 | Completed | Senju USA, Inc. | 122 | 2009-02-01 | 2023-08-04 |
| Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration Patch, Placebo patch - Allergic Rhinoconjunctivitis | Phase 2 | Completed | University of Zurich | 97 | 2008-10-01 | 2011-02-01 |
| A Dose-Finding Study of Fentanyl (JNS020 QD) 1-Day Transdermal Patch in Participants With Cancer Pain Fentanyl 1-day transdermal patch (Titration Phase), Fentanyl 1-day transdermal patch (Double Blind Phase), Fentanyl 3-day transdermal patch (Double Blind Phase) - Pain, Cancer | Phase 2 / Phase 3 | Completed | Janssen Pharmaceutical K.K. | 156 | 2007-12-01 | 2013-06-13 |
| Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee Lidoderm (Lidocaine 5% Patch), Placebo Patch - Osteoarthritis of the Knee | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 169 | 2007-03-01 | 2017-10-05 |
| Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia Transdermal/Patch (Bupivacaine TTS [Eladur™]) - Postherpetic Neuralgia, Pain | Phase 2 | Completed | Durect | 60 | 2006-09-01 | 2009-09-11 |
| Pilot Study of Lidocaine 5% Patch Versus Placebo in Patients With Osteoarthritis Pain of the Knee Lidoderm, Placebo patch - Osteoarthritis, Knee | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 224 | 2004-08-01 | 2010-02-10 |
| A Study Comparing The Efficacy And Safety Of Lidocaine 5% Patch With Placebo In Patients With Chronic Axial Low Back Pain Lidoderm®, Placebo Topical Patch - Chronic Low Back Pain | Phase 2 | Completed | Endo USA Inc., a Keenova Therapeutics Company | 215 | 2004-08-01 | 2013-12-06 |
| Testosterone Replacement Therapy in Chronic Spinal Cord Injury Testosterone Transdermal System (Androderm 5 mg patch) - Spinal Cord Injury, Hypogonadism | Phase 2 / Phase 3 | Completed | VA Office of Research and Development | 31 | 2003-08-01 | 2017-11-01 |
Pain (3) · Osteoarthritis, Knee (2) · Carpal Tunnel Syndrome (1) · Conjunctivitis, Allergic (1) · Epidermolysis Bullosa (1) · Herpes Zoster (1) · Hypogonadism (1) · Neoplasms (1) · Neuralgia (1) · Neuralgia, Postherpetic (1) · Osteoarthritis (1) · Spinal Cord Injuries (1) · Transsexualism (1)
Endo USA Inc., a Keenova Therapeutics Company (3) · Agile Therapeutics (1) · Albany Medical College (1) · Birken AG (1) · Durect (1) · Janssen Pharmaceutical K.K. (1) · Senju USA, Inc. (1) · State University of New York at Buffalo (1) · University of Zurich (1) · VA Office of Research and Development (1) · Washington University School of Medicine (1) · ZARS Pharma Inc. (1)
United States (10) · Germany (1) · Japan (1) · Switzerland (1)
Agnes Schwieger-Briel, MD (1) · Elizabeth Garner, MD, PHD (1) · Ernest A. Kopecky, PhD, MBA (1) · Gail Torkildsen, MD (1) · Ginger Nicol, MD (1) · Srinivas Nalamachu, MD (1) · William Bauman, MD (1)
PMID 21252493, PMID 21717386, PMID 23343764, PMID 24968251, PMID 38133914, PMID 42947186
UH3TR004797 (1)